Huadong Medicine Co., Ltd (SHE:000963)
38.85
+1.44 (3.85%)
Apr 30, 2025, 3:04 PM CST
Huadong Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 3,712 | 5,276 | 4,663 | 3,996 | 4,032 | 3,198 | Upgrade
|
Cash & Short-Term Investments | 3,712 | 5,276 | 4,663 | 3,996 | 4,032 | 3,198 | Upgrade
|
Cash Growth | 4.18% | 13.15% | 16.69% | -0.90% | 26.09% | 33.10% | Upgrade
|
Accounts Receivable | 12,546 | 10,114 | 8,896 | 8,210 | 6,940 | 6,966 | Upgrade
|
Other Receivables | 571.87 | 402.87 | 291.14 | 284.18 | 223.92 | 87.63 | Upgrade
|
Receivables | 13,118 | 10,517 | 9,188 | 8,494 | 7,164 | 7,054 | Upgrade
|
Inventory | 4,993 | 4,776 | 4,290 | 4,495 | 3,975 | 4,068 | Upgrade
|
Prepaid Expenses | - | 0.09 | 15.07 | - | - | - | Upgrade
|
Other Current Assets | 583.94 | 482.3 | 340.46 | 582.21 | 316.04 | 336.21 | Upgrade
|
Total Current Assets | 22,407 | 21,052 | 18,497 | 17,568 | 15,487 | 14,656 | Upgrade
|
Property, Plant & Equipment | 5,427 | 5,409 | 5,204 | 5,021 | 4,813 | 4,661 | Upgrade
|
Long-Term Investments | 2,225 | 2,147 | 2,101 | 2,020 | 1,243 | 1,076 | Upgrade
|
Goodwill | 2,919 | 2,913 | 2,599 | 2,441 | 2,139 | 1,470 | Upgrade
|
Other Intangible Assets | 3,786 | 3,645 | 2,334 | 2,280 | 2,233 | 1,463 | Upgrade
|
Long-Term Deferred Tax Assets | 223.51 | 221.85 | 187.81 | 152.84 | 143.65 | 137.83 | Upgrade
|
Long-Term Deferred Charges | 1,141 | 1,056 | 1,013 | 657.81 | 12.43 | 8.81 | Upgrade
|
Other Long-Term Assets | 1,318 | 1,436 | 1,574 | 1,051 | 925.63 | 729.86 | Upgrade
|
Total Assets | 39,447 | 37,879 | 33,509 | 31,192 | 26,996 | 24,201 | Upgrade
|
Accounts Payable | 7,742 | 7,044 | 6,102 | 5,902 | 4,520 | 4,501 | Upgrade
|
Accrued Expenses | 219.91 | 650.63 | 554.92 | 518.92 | 920.63 | 528.8 | Upgrade
|
Short-Term Debt | 2,453 | 2,665 | 1,197 | 1,337 | 1,627 | 1,808 | Upgrade
|
Current Portion of Long-Term Debt | 110.78 | 212.41 | 80.92 | 36.9 | 174.18 | 40.05 | Upgrade
|
Current Portion of Leases | - | 67.3 | 81.98 | 75.29 | 66.86 | - | Upgrade
|
Current Income Taxes Payable | 669.77 | 370.26 | 259.27 | 154.95 | 261.24 | 166.43 | Upgrade
|
Current Unearned Revenue | 177.42 | 174.72 | 136.85 | 147.64 | 119.49 | 95.34 | Upgrade
|
Other Current Liabilities | 2,978 | 2,610 | 2,389 | 1,979 | 1,576 | 1,494 | Upgrade
|
Total Current Liabilities | 14,351 | 13,794 | 10,803 | 10,153 | 9,266 | 8,634 | Upgrade
|
Long-Term Debt | 14.64 | 14.26 | 520.76 | 1,051 | 139.18 | 151.61 | Upgrade
|
Long-Term Leases | 89.14 | 71.86 | 56.7 | 84.61 | 80.89 | - | Upgrade
|
Long-Term Unearned Revenue | 180.77 | 183.86 | 171.06 | 126.12 | 83.52 | 81.63 | Upgrade
|
Long-Term Deferred Tax Liabilities | 196.42 | 197.38 | 184.37 | 202.08 | 184.91 | 88.74 | Upgrade
|
Other Long-Term Liabilities | 52.17 | 53.7 | 191.61 | 398.67 | 300.99 | 66.28 | Upgrade
|
Total Liabilities | 14,884 | 14,315 | 11,927 | 12,016 | 10,055 | 9,022 | Upgrade
|
Common Stock | 1,754 | 1,754 | 1,754 | 1,754 | 1,750 | 1,750 | Upgrade
|
Additional Paid-In Capital | 2,549 | 2,551 | 2,446 | 2,378 | 2,230 | 2,158 | Upgrade
|
Retained Earnings | 19,767 | 18,852 | 16,972 | 14,639 | 12,647 | 10,714 | Upgrade
|
Treasury Stock | -42.17 | -46.8 | -84.52 | -104.65 | - | - | Upgrade
|
Comprehensive Income & Other | 31.45 | -50.6 | -40.34 | -88.55 | -47.77 | -2.19 | Upgrade
|
Total Common Equity | 24,060 | 23,060 | 21,048 | 18,578 | 16,579 | 14,620 | Upgrade
|
Minority Interest | 503.01 | 503.7 | 534.65 | 598.52 | 361.94 | 559.59 | Upgrade
|
Shareholders' Equity | 24,563 | 23,564 | 21,582 | 19,176 | 16,941 | 15,179 | Upgrade
|
Total Liabilities & Equity | 39,447 | 37,879 | 33,509 | 31,192 | 26,996 | 24,201 | Upgrade
|
Total Debt | 2,668 | 3,031 | 1,938 | 2,586 | 2,089 | 1,999 | Upgrade
|
Net Cash (Debt) | 1,044 | 2,246 | 2,726 | 1,411 | 1,944 | 1,199 | Upgrade
|
Net Cash Growth | -44.36% | -17.61% | 93.21% | -27.43% | 62.16% | 267.04% | Upgrade
|
Net Cash Per Share | 0.60 | 1.28 | 1.56 | 0.81 | 1.11 | 0.69 | Upgrade
|
Filing Date Shares Outstanding | 1,751 | 1,759 | 1,752 | 1,750 | 1,750 | 1,750 | Upgrade
|
Total Common Shares Outstanding | 1,751 | 1,759 | 1,752 | 1,750 | 1,750 | 1,750 | Upgrade
|
Working Capital | 8,056 | 7,258 | 7,694 | 7,415 | 6,221 | 6,022 | Upgrade
|
Book Value Per Share | 13.74 | 13.11 | 12.01 | 10.62 | 9.47 | 8.36 | Upgrade
|
Tangible Book Value | 17,355 | 16,502 | 16,115 | 13,856 | 12,207 | 11,687 | Upgrade
|
Tangible Book Value Per Share | 9.91 | 9.38 | 9.20 | 7.92 | 6.98 | 6.68 | Upgrade
|
Buildings | - | 2,483 | 2,299 | 1,865 | 1,503 | 1,228 | Upgrade
|
Machinery | - | 5,010 | 4,438 | 4,282 | 3,385 | 2,817 | Upgrade
|
Construction In Progress | - | 836.74 | 913.15 | 873.16 | 1,582 | 2,240 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.